Crossmark

The Treatment Effect of Protamine on Severe Coagulopathy in Epstein–Barr Virus-Associated Hemophagocytic Lymphohistiocytosis: Case Reports and Literature Review

Crossref DOI link: https://doi.org/10.1007/s12288-020-01308-6

Published Online: 2020-08-12

Published Print: 2021-01

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Zhang, Qian

Yan, CunLiang

Xu, Lei

Xie, Wenyue

Li, JinMeng

Zhang, Wenli

Xu, HaiChan

Zhang, HongYu
Funding

Funding for this research was provided by:

Clinical research of safety and effectiveness of anti CD19 chimeric antigen receptor T cell immunotherapy in relapsed and refractory B cell lymphoma ((SZXJ2018081))
License Information

Text and Data Mining valid from 2020-08-12

Version of Record valid from 2020-08-12
More Information

Article History

Received: 2 August 2019

Accepted: 12 June 2020

First Online: 12 August 2020

Compliance with ethical standards

:

: None.

: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

: Informed consent was obtained from all individual participants included in the study.

Document is current

Any future updates will be listed below